FDN - Parkinson's Disease: The Hidden Battle in Your Gut w/ Martha Carlin
by Kevin Danielson August 27, 2024
In this episode, transformational leader Martha Carlin discusses her journey from business operations to becoming a citizen scientist in the field of microbiome research. As the founder of the BioCollective and BiotiQuest, Carlin shares insights into the gut microbiome's impact on diseases like Parkinson's, her groundbreaking research, and the development of targeted probiotics.
Behind closed eyes, the brain is carrying out a carefully coordinated night shift. And research into the microbiome raises an intriguing question: how might the activity in our gut influence the sleep that gives this work its opportunity?
When discussing gut health, the conversation usually centers on the microbiome. While balancing gut bacteria remains essential, cutting-edge science highlights another critical component of cellular health: the glycocalyx.
When discussing chronic neurological conditions like Parkinson’s disease, conventional medicine frequently focuses on a single narrative: dopamine depletion. While managing neurotransmitters remains a core part of traditional care, emerging physical chemistry and microbiome research reveal a far broader picture.